HopeStage
Back to overview

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Topics
More filters
2276studies shown
Showing 1,909-1,920 of 2,276
Drug study icon
CompletedACTRN12619000683134

Ketamine for Youth Depression

Official study title

Study of Ketamine for Youth Depression

This study has finished and is no longer accepting participants.

In Australia
DepressionInterventional studyAges 16–25
Countries
Australia
Sponsor
Orygen, the National Centre of Excellence in Youth Mental Health
Drug study icon
CompletedNCT01515423

Paliperidone Palmitate 3 Month and 1 Month Formulations for people with Schizophrenia

Official study title

A Randomized, Multicenter, Double-Blind, Non-inferiority Study of Paliperidone Palmitate 3 Month and 1 Month Formulations for the Treatment of Subjects With Schizophrenia

This study has finished and is no longer accepting participants.

In Australia
SchizophreniaMedication studyAges 18–70
Countries
Australia, United States, France, + 23 others
Sponsor
Janssen Research & Development, LLC
Drug study icon
Active Not RecruitingNCT06442462

SPG302 in Adults With Schizophrenia

What is this study about?

This study evaluates the safety and effectiveness of SPG302 for people with schizophrenia.

This study is no longer accepting new participants.

In Australia
SchizophreniaMedication studyAges 18–65
Countries
Australia, United States
Sponsor
Spinogenix
Drug study icon
WithdrawnACTRN12619001569190

Safety study of risperidone Extended Release Capsules in schizophrenia

Official study title

Open-Label Single Dose Pilot Study to Assess Safety, Tolerability and Pharmacokinetics of Risperidone Extended Release Capsules in Patients with Schizophrenia, Schizoaffective Disorder or Bipolar 1 Disorder

This study was withdrawn before enrollment.

In Australia
Bipolarity, SchizophreniaInterventional studyAges 18–49
Countries
Australia
Sponsor
Lyndra Australia Pty Ltd
Drug study icon
CompletedNCT01072630

Armodafinil Treatment for depression

Official study title

A Double-Blind, Placebo-Controlled, Parallel-Group, Fixed-Dosage Study to Evaluate the Efficacy and Safety of Armodafinil Treatment (150 and 200 mg/Day) as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder

This study has finished and is no longer accepting participants.

In Australia
Bipolarity, DepressionMedication studyAges 18–65
Countries
Australia, United States, France, + 7 others
Sponsor
Cephalon
Drug study icon
CompletedACTRN12625000020482

Safety study of ascending doses of KNX100 in Mental health

Official study title

KTX-003: A Phase 1 Study evaluating the Safety, Tolerability and Pharmacokinetics of ascending doses of KNX100 in healthy young and elderly volunteers.

This study has finished and is no longer accepting participants.

In Australia
Mental healthInterventional studyAges 18+
Countries
Australia
Sponsor
Kinoxis Therapeutics Pty Ltd
Other study type icon
CompletedNCT05860959

SUBLOCADE Long-term Outcomes

Official study title

A Phase IV Longitudinal Study of SUBLOCADE (SUBUTEX Prolonged Release) Clinical Outcomes in Adults With Opioid Use Disorder (Opioid Dependence)

This study has finished and is no longer accepting participants.

In Australia
AddictionObservational studyAges 18+
Countries
Australia, United States, Canada, + 1 other
Sponsor
Indivior Inc.
Other study type icon
WithdrawnACTRN12621000542897

Suicide prevention and Suicide prevention in vulnerable prisoners: Evaluating a new service intervention involving a structured approach to risk assessment and management

Official study title

Self-harm and suicidality in vulnerable prisoners: Evaluating a new service intervention involving a structured approach to risk assessment and management

This study was withdrawn before enrollment.

In Australia
SuicidalityInterventional studyAges 18+
Countries
Australia
Sponsor
University of New South Wales
Behavioral study icon
CompletedACTRN12618001330235

Suicide prevention Education for the Public: How effective is Addressing the Bystander Effect through the Bystander Intervention Model in increasing knowledge, confidence and intent to intervene?

Official study title

The Efficacy of Online Suicide Prevention Education for the Public Addressing the Bystander Effect through the Bystander Intervention Model in increasing knowledge, confidence and intent to intervene: An RCT.

This study has finished and is no longer accepting participants.

In Australia
SuicidalityInterventional studyAges 18+
Countries
Australia
Sponsor
Australian Catholic University
Other study type icon
CompletedACTRN12623000084684

Suicide prevention using Google AdWords: A study measuring Engagement

Official study title

A Randomised Trial measuring Engagement with an ad and landing page designed for suicide prevention using Google Adwords for participants in Australia

This study has finished and is no longer accepting participants.

In Australia
SuicidalityInterventional studyAges 18+
Countries
Australia
Sponsor
University of New South Wales
Behavioral study icon
CompletedACTRN12625000970448

Support for families to motivate treatment-refusing heavy gamblers to reduce their gambling and seek help: A study

Official study title

The family reinforcement and contingency management approach for friends and families of heavy gamblers: A feasibility single-blinded parallel two-arm pragmatic randomised control trial

This study has finished and is no longer accepting participants.

In Australia
AddictionInterventional studyAges 18+
Countries
Australia
Sponsor
Southern Adelaide Local Health Network
Behavioral study icon
CompletedACTRN12614000353695

Supporting aged care nursing staff to electronically manage resident’s behavioural and psychological symptoms of dementia in real time.

Official study title

A program to support aged care nursing staff to electronically manage resident’s behavioural and psychological symptoms of dementia in real time using a web-based application.

This study has finished and is no longer accepting participants.

In Australia
Mental healthInterventional studyAges 18+
Countries
Australia
Sponsor
Federation University

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.